पहले दिल्ली और अब लखनऊ में कार्डियक अरेस्ट से बच्चों की मौत, कम उम्र में क्यों हो रही दिल की बीमारी?

The insurer says its existing distribution cost controls offer protection, even as it prepares to align certain products with revised norms

The company reported a net profit of ₹114.54 crore in Q2FY27, down from ₹119.66 crore in Q2FY26.

This initiative succeeded in breaking the deadlock between sugarcane farmers and factories, allowing commencement of operations in sugar factories

Pharma stocks on a roll: Symbiotec Pharmalab, Windlas Biotech, Sai Life Sciences, Alembic Pharmaceuticals and Fermation Biotech were up in the range of 9-20% on Friday.